Ketamine + Cognitive Training for Suicidality in the Medical Setting
Brief Summary
This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Intervention / Treatment
-
Drug: Intravenous Ketamine
-
Behavioral: Cognitive training
-
Behavioral: Sham Training
Condition or Disease
- Suicide, Attempted
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Enrolling by invitation |
| Study results: | No Results Available |
| Age: | 18 Years to 65 Years (Adult, Older Adult) |
| Enrollment: | 80 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Dec 19, 2019 | |
|---|---|---|
| Primary Completion: | Jan 23, 2020 | |
| Completion Date: | Jan 24, 2020 | |
| Study First Posted: | Nov 06, 2019 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Jan 18, 2020 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 65 |
More Details
| NCT Number: | NCT04154150 |
|---|---|
| Other IDs: | STUDY19100041 |
| Study URL: | https://ClinicalTrials.gov/show/NCT04154150 |
Last updated: Jun 17, 2022